CLSD Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | Gibney Anthony S | director | 45,000 | A-Award | A | 45,000 | 1.29 | 58,050.00 |
| 2024-04-15 | Gibney Anthony S | 0 | 0 | 0.00 | 0.00 | |||
| 2024-03-20 | Chong Ngai Hang Victor | officer: CHIEF MEDICAL OFFICER | 30,000 | P-Purchase | A | 30,000 | 1.60 | 48,000.00 |
| 2024-03-18 | Chong Ngai Hang Victor | officer: CHIEF MEDICAL OFFICER | 450,000 | A-Award | A | 450,000 | 1.56 | 702,000.00 |
| 2024-03-14 | Chong Ngai Hang Victor | 0 | 0 | 0.00 | 0.00 | |||
| 2024-02-07 | WHITMORE BRADFORD T | 10 percent owner | 4,495,034 | P-Purchase | A | 444,444 | 1.35 | 599,999.00 |
| 2024-02-07 | WHITMORE BRADFORD T | 10 percent owner | 444,444 | P-Purchase | A | 444,444 | 1.62 | 719,999.00 |
| 2024-01-19 | LASEZKAY GEORGE M | director, officer: CEO | 466,577 | S-Sale | D | 18,000 | 1.27 | 22,860.00 |
| 2024-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 439,500 | A-Award | A | 439,500 | 1.29 | 566,955.00 |
| 2024-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 384,662 | S-Sale | D | 12,900 | 1.28 | 16,512.00 |
| 2024-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 200,000 | A-Award | A | 200,000 | 1.29 | 258,000.00 |
| 2023-11-01 | WHITMORE BRADFORD T | 10 percent owner | 4,050,590 | P-Purchase | A | 64,366 | 0.74 | 47,901.00 |
| 2023-10-31 | WHITMORE BRADFORD T | 10 percent owner | 3,986,224 | P-Purchase | A | 70,812 | 0.73 | 51,537.00 |
| 2023-10-30 | WHITMORE BRADFORD T | 10 percent owner | 3,915,412 | P-Purchase | A | 600 | 0.69 | 411.00 |
| 2023-10-27 | WHITMORE BRADFORD T | 10 percent owner | 3,914,812 | D | 0 | 0.00 | 0.00 | |
| 2023-10-27 | WHITMORE BRADFORD T | 10 percent owner | 2,350,152 | I | 0 | 0.00 | 0.00 | |
| 2023-10-03 | Hutson Nancy J | director | 93,000 | P-Purchase | A | 10,000 | 0.86 | 8,600.00 |
| 2023-09-25 | Thorp Clay | director | 40,522 | P-Purchase | A | 10,000 | 0.86 | 8,600.00 |
| 2023-09-22 | Humphries William D. | director | 51,040 | M-Exempt | A | 22,727 | 0.40 | 9,091.00 |
| 2023-09-22 | Humphries William D. | director | 0 | M-Exempt | D | 22,727 | 0.40 | 9,091.00 |
| 2023-09-18 | Deignan Charles A. | officer: Chief Financial Officer | 100,000 | A-Award | A | 100,000 | 0.85 | 84,900.00 |
| 2023-09-18 | LASEZKAY GEORGE M | director, officer: CEO | 200,000 | A-Award | A | 200,000 | 0.85 | 169,800.00 |
| 2023-09-13 | Deignan Charles A. | officer: Chief Financial Officer | 397,562 | M-Exempt | A | 34,090 | 0.40 | 13,636.00 |
| 2023-09-13 | Deignan Charles A. | officer: Chief Financial Officer | 0 | M-Exempt | D | 34,090 | 0.40 | 13,636.00 |
| 2023-06-22 | Thorp Clay | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | Croarkin Richard | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | EDWARDS JEFFREY L | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | Humphries William D. | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | Hutson Nancy J | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | SHAFFER CHRISTY L | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-06-22 | YERXA BENJAMIN R | director | 30,000 | A-Award | A | 30,000 | 1.31 | 39,300.00 |
| 2023-01-20 | Ciulla Thomas | officer: Chief Medical Officer | 291,890 | S-Sale | D | 13,700 | 1.47 | 20,139.00 |
| 2023-01-19 | LASEZKAY GEORGE M | officer: CEO | 484,577 | S-Sale | D | 20,030 | 1.46 | 29,244.00 |
| 2023-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 363,472 | S-Sale | D | 14,030 | 1.50 | 21,045.00 |
| 2023-01-10 | Ciulla Thomas | officer: Chief Medical Officer | 305,590 | S-Sale | D | 2,170 | 1.62 | 3,515.00 |
| 2023-01-04 | LASEZKAY GEORGE M | officer: CEO | 487,500 | A-Award | A | 487,500 | 0.00 | 0.00 |
| 2023-01-04 | Deignan Charles A. | officer: Chief Financial Officer | 187,500 | A-Award | A | 187,500 | 0.00 | 0.00 |
| 2022-12-31 | Ciulla Thomas | officer: Chief Medical Officer | 307,760 | A-Award | A | 5,000 | 0.95 | 4,750.00 |
| 2022-06-30 | Ciulla Thomas | officer: Chief Medical Officer | 302,760 | A-Award | A | 5,000 | 1.25 | 6,250.00 |
| 2023-01-04 | Ciulla Thomas | officer: Chief Medical Officer | 187,500 | A-Award | A | 187,500 | 0.00 | 0.00 |
| 2022-12-21 | Thorp Clay | director | 30,522 | P-Purchase | A | 14,000 | 1.02 | 14,266.00 |
| 2022-12-20 | Deignan Charles A. | officer: Chief Financial Officer | 377,502 | M-Exempt | A | 23,636 | 0.40 | 9,454.00 |
| 2022-12-20 | Deignan Charles A. | officer: Chief Financial Officer | 0 | M-Exempt | D | 23,636 | 0.00 | 0.00 |
| 2022-12-15 | Thorp Clay | director | 3,545,040 | J-Other | D | 1,406,507 | 0.00 | 0.00 |
| 2022-12-15 | Thorp Clay | director | 16,522 | J-Other | A | 8,522 | 0.00 | 0.00 |
| 2021-02-10 | Thorp Clay | director | 4,951,547 | S-Sale | D | 32,873 | 4.43 | 145,627.00 |
| 2022-11-17 | Hutson Nancy J | director | 83,000 | P-Purchase | A | 30,000 | 1.33 | 39,900.00 |
| 2022-06-22 | SHAFFER CHRISTY L | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | YERXA BENJAMIN R | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | Hutson Nancy J | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | Hutson Nancy J | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Croarkin Richard | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | EDWARDS JEFFREY L | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | EDWARDS JEFFREY L | director | 30,000 | A-Award | A | 30,000 | 1.62 | 48,600.00 |
| 2022-06-22 | Humphries William D. | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-06-22 | Thorp Clay | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-03-02 | YERXA BENJAMIN R | director: | 30,000 | A-Award | A | 30,000 | 0.00 | 0.00 |
| 2022-03-02 | YERXA BENJAMIN R | director | 10,144 | D | 0 | 0.00 | 0.00 | |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 301,810 | A-Award | A | 46,250 | 0.00 | 0.00 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 138,750 | A-Award | A | 138,750 | 2.19 | 303,862.00 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 362,699 | A-Award | A | 46,250 | 0.00 | 0.00 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 138,750 | A-Award | A | 138,750 | 2.19 | 303,862.00 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 360,199 | A-Award | A | 43,750 | 0.00 | 0.00 |
| 2022-01-19 | Deignan Charles A. | officer: Chief Financial Officer | 351,366 | S-Sale | D | 8,833 | 2.09 | 18,461.00 |
| 2022-01-18 | Deignan Charles A. | officer: Chief Financial Officer | 131,250 | A-Award | A | 131,250 | 2.19 | 287,438.00 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 299,310 | A-Award | A | 43,750 | 0.00 | 0.00 |
| 2022-01-19 | Ciulla Thomas | officer: Chief Medical Officer | 295,260 | S-Sale | D | 9,050 | 2.13 | 19,276.00 |
| 2022-01-18 | Ciulla Thomas | officer: Chief Medical Officer | 131,250 | A-Award | A | 131,250 | 2.19 | 287,438.00 |
| 2022-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 515,407 | A-Award | A | 97,500 | 0.00 | 0.00 |
| 2022-01-19 | LASEZKAY GEORGE M | director, officer: CEO | 504,607 | S-Sale | D | 10,800 | 2.12 | 22,896.00 |
| 2022-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 292,500 | A-Award | A | 292,500 | 2.19 | 640,575.00 |
| 2022-01-11 | LASEZKAY GEORGE M | director, officer: CEO | 417,907 | S-Sale | D | 5,100 | 2.46 | 12,546.00 |
| 2022-01-10 | Humphries William D. | director | 28,313 | M-Exempt | A | 22,727 | 0.15 | 3,409.00 |
| 2022-01-10 | Humphries William D. | director | 0 | M-Exempt | D | 22,727 | 0.15 | 3,409.00 |
| 2021-10-29 | Hutson Nancy J | director | 53,000 | M-Exempt | A | 15,000 | 2.09 | 31,350.00 |
| 2021-10-29 | Hutson Nancy J | director | 38,000 | M-Exempt | A | 25,000 | 2.00 | 50,000.00 |
| 2021-10-29 | Hutson Nancy J | director | 15,000 | M-Exempt | D | 15,000 | 2.09 | 31,350.00 |
| 2021-10-29 | Hutson Nancy J | director | 0 | M-Exempt | D | 25,000 | 2.00 | 50,000.00 |
| 2021-09-21 | Ciulla Thomas | officer: Chief Medical Officer | 255,560 | S-Sale | D | 2,560 | 6.40 | 16,384.00 |
| 2021-09-21 | LASEZKAY GEORGE M | director, officer: CEO | 423,007 | S-Sale | D | 3,525 | 6.46 | 22,772.00 |
| 2021-09-21 | Deignan Charles A. | officer: Chief Financial Officer | 316,449 | S-Sale | D | 2,800 | 6.41 | 17,948.00 |
| 2021-08-30 | WHITMORE BRADFORD T | 10 percent owner | 2,735,941 | S-Sale | D | 99,400 | 7.06 | 702,102.00 |
| 2021-08-31 | WHITMORE BRADFORD T | 10 percent owner | 2,628,259 | S-Sale | D | 107,682 | 6.96 | 749,079.00 |
| 2021-09-01 | WHITMORE BRADFORD T | 10 percent owner | 2,415,056 | S-Sale | D | 213,203 | 6.89 | 1,469,246.00 |
| 2021-08-16 | Hutson Nancy J | director | 13,000 | P-Purchase | A | 3,000 | 5.68 | 17,040.00 |
| 2021-06-21 | LASEZKAY GEORGE M | director, officer: CEO | 426,532 | S-Sale | D | 3,707 | 4.38 | 16,237.00 |
| 2021-06-21 | Deignan Charles A. | officer: Chief Financial Officer | 319,249 | S-Sale | D | 2,938 | 4.37 | 12,839.00 |
| 2021-06-10 | Hutson Nancy J | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Croarkin Richard | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | EDWARDS JEFFREY L | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Humphries William D. | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | Thorp Clay | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-06-10 | SHAFFER CHRISTY L | director | 25,000 | A-Award | A | 25,000 | 3.11 | 77,750.00 |
| 2021-03-19 | LASEZKAY GEORGE M | director, officer: CEO | 430,239 | S-Sale | D | 3,370 | 2.82 | 9,503.00 |
| 2021-03-12 | Hutson Nancy J | director | 10,000 | P-Purchase | A | 5,000 | 3.11 | 15,525.00 |
| 2021-03-02 | LASEZKAY GEORGE M | director, officer: CEO | 433,609 | S-Sale | D | 6,000 | 3.37 | 20,220.00 |
| 2021-03-01 | Ciulla Thomas | officer: Chief Medical Officer | 40,000 | A-Award | A | 40,000 | 5.04 | 201,600.00 |
| 2021-02-10 | Thorp Clay | director | 3,433,521 | S-Sale | D | 32,873 | 4.43 | 145,627.00 |
| 2021-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 439,609 | A-Award | A | 140,250 | 0.00 | 0.00 |
| 2021-01-18 | LASEZKAY GEORGE M | director, officer: CEO | 284,750 | A-Award | A | 284,750 | 4.01 | 1,141,848.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
